Washington Institute For Coagulation (WIC) is a clinical research site located in Seattle, Washington, United States 98101.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Washington Institute For Coagulation (WIC) has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2.
Sponsors: Hemab ApS.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Washington Institute For Coagulation (WIC) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Washington Institute For Coagulation (WIC) has 1 clinical trials on record, with 1 currently active. Their work covers Von Willebrand Disease (VWD), Von Willebrand Disease (VWD), Type 1, Von Willebrand Disease (VWD), Type 2.
Washington Institute For Coagulation (WIC) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.